Pulmonary Surgical Margins for Metastatic Osteosarcoma: Is Negative Margin Enough?


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
03 Jun 2024
Historique:
received: 05 11 2023
revised: 07 05 2024
accepted: 13 05 2024
medline: 6 6 2024
pubmed: 6 6 2024
entrez: 5 6 2024
Statut: aheadofprint

Résumé

In advanced osteosarcoma, the lung is the most frequent site of distant metastasis, with metastasectomy often utilized for local control. The influence of pulmonary resection margin length on outcomes for osteosarcoma has not been well explored. We sought to evaluate the impact of margin length relative to tumor size on local recurrence and survival in lung-limited metastatic osteosarcoma. Patients with metastatic osteosarcoma who underwent lung resection between 2000-2020 were identified from a single institution. Clinicopathologic variables were collected. Margin length-to-tumor size ratio (MTR) was calculated per nodule and classified relative to MTR of 0.5. The primary outcome was development of local recurrence per nodule. Multivariate logistic regression was used to investigate covariates. 142 patients with 689 nodules met inclusion criteria, with mean age of 35.6 years (IQR 20.9-46.6). Patients were predominantly male (n=87, 61.3%) and White (n=106, 72.5%). Most nodules (n=644, 93.5%) were resected via thoracotomy. Mean tumor size was 0.8 cm (IQR 0.5-1.70), with average margin length of 0.3 cm (IQR 0.1-0.7). Among all nodules, 299 (43.4%) had MTR > 0.5. Systemic therapy was received by 94 patients (66.2%) preoperatively and 100 patients (70.4%) postoperatively. Importantly, we found that MTR >0.5 conferred a protective effect against recurrence (HR: 0.67, 95% CI: 0.52-0.87, p=0.003). In resected pulmonary metastatic osteosarcoma, margin length greater than half the size of the pulmonary nodule is associated with lower incidence of local recurrence, with implications for subsequent need for additional therapy and disease-free state, meriting attentive intraoperative consideration.

Sections du résumé

BACKGROUND BACKGROUND
In advanced osteosarcoma, the lung is the most frequent site of distant metastasis, with metastasectomy often utilized for local control. The influence of pulmonary resection margin length on outcomes for osteosarcoma has not been well explored. We sought to evaluate the impact of margin length relative to tumor size on local recurrence and survival in lung-limited metastatic osteosarcoma.
METHODS METHODS
Patients with metastatic osteosarcoma who underwent lung resection between 2000-2020 were identified from a single institution. Clinicopathologic variables were collected. Margin length-to-tumor size ratio (MTR) was calculated per nodule and classified relative to MTR of 0.5. The primary outcome was development of local recurrence per nodule. Multivariate logistic regression was used to investigate covariates.
RESULTS RESULTS
142 patients with 689 nodules met inclusion criteria, with mean age of 35.6 years (IQR 20.9-46.6). Patients were predominantly male (n=87, 61.3%) and White (n=106, 72.5%). Most nodules (n=644, 93.5%) were resected via thoracotomy. Mean tumor size was 0.8 cm (IQR 0.5-1.70), with average margin length of 0.3 cm (IQR 0.1-0.7). Among all nodules, 299 (43.4%) had MTR > 0.5. Systemic therapy was received by 94 patients (66.2%) preoperatively and 100 patients (70.4%) postoperatively. Importantly, we found that MTR >0.5 conferred a protective effect against recurrence (HR: 0.67, 95% CI: 0.52-0.87, p=0.003).
CONCLUSIONS CONCLUSIONS
In resected pulmonary metastatic osteosarcoma, margin length greater than half the size of the pulmonary nodule is associated with lower incidence of local recurrence, with implications for subsequent need for additional therapy and disease-free state, meriting attentive intraoperative consideration.

Identifiants

pubmed: 38839027
pii: S0003-4975(24)00440-5
doi: 10.1016/j.athoracsur.2024.05.023
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024. Published by Elsevier Inc.

Auteurs

Michael Eisenberg (M)

Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Nathaniel Deboever (N)

Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Wayne L Hofstetter (WL)

Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Reza J Mehran (RJ)

Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

David C Rice (DC)

Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Ravi Rajaram (R)

Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Stephen G Swisher (SG)

Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Ara A Vaporciyan (AA)

Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Garrett L Walsh (GL)

Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

Mara B Antonoff (MB)

Thoracic and Cardiovascular Surgery, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Electronic address: mbantonoff@mdanderson.org.

Classifications MeSH